Heyman Richard A. Insider Trading Activity
Heyman Richard A. has been net-selling over the last 12 months with 0 purchases and 9 sales across 2 different companies.
ELVN is the most-traded position with 6 trades. The largest single transaction was a sale of ELVN for $201K on Jan 8, 2026.
Performance Scorecard
Forward stock performance after each transaction by Heyman Richard A.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.0% | 50% | 8 |
| 90 days | — | -49.4% | 25% | 8 |
| 120 days | — | -37.6% | 25% | 8 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Heyman Richard A. bought and sold ELVN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 6, 2026 | ORIC | Sell | 300 | $12.00 | $4K | −0.1% | Director | |
Feb 17, 2026 | ELVN | Sell | 1,230 | $26.18 | $32K | −5.2% | Director | |
Jan 20, 2026 | ELVN | Sell | 512 | $26.46 | $14K | −2.0% | Director | |
Jan 20, 2026 | ELVN | Sell | 718 | $26.96 | $19K | −2.9% | Director | |
Jan 16, 2026 | ORIC | Sell | 3,200 | $12.00 | $38K | −1.5% | Director | |
Jan 16, 2026 | ORIC | Sell | 3,500 | $12.00 | $42K | −7.7% | Director | |
Jan 9, 2026 | ELVN | Sell | 4,285 | $25.00 | $107K | −14.6% | Director | |
Jan 8, 2026 | ELVN | Sell | 1,620 | $25.00 | $41K | −6.0% | Director | |
Jan 8, 2026 | ELVN | Sell | 8,015 | $25.04 | $201K | −21.4% | Director |
Top Companies Traded
Other insiders at Enliven Therapeutics, Inc.
5 other tracked filers at ELVN.